Hypertensive crisis in systemic sclerosis: treatment with the new oral angiotensin converting enzyme inhibitor MK, 421 (Enalapril) in captopril-intolerant patients.
D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors; D002216:Captopril / Q000009:adverse effects* / Q000627:therapeutic use; D004151:Dipeptides / Q000627:therapeutic use*; D004361:Drug Tolerance; D004656:Enalapril; D005260:Female; D006801:Humans; D006974:Hypertension, Malignant / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011392:Proline / Q000031:analogs & derivatives*; D012595:Scleroderma, Systemic / Q000150:complications*
D000806:Angiotensin-Converting Enzyme Inhibitors; D004151:Dipeptides; D004656:Enalapril; D011392:Proline; D002216:Captopril